ArticleFrontiers in microbiology2025
Risk factors for Carbapenem-resistant
Article in Frontiers in microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Multiphase terminal environmental disinfection targeting Acinetobacter baumannii sustains reduction in multidrug-resistant organism healthcare-associated infections in an ICU.Antimicrobial resistance and infection control · 2026Article
- Comparative genomic and resistance characterization of ST2 and ST164 carbapenem-resistantMicrobial genomics · 2026Article
- Outer membrane vesicles of carbapenem-resistantMicrobiology spectrum · 2026Article
- Ward microclimate and procedural factors as predictors for CRAB environmental contamination in ICUs: a longitudinal monitoring study.Antimicrobial resistance and infection control · 2026Article
- Contamination of reusable cleaning tools in healthcare settings: a study based on the longitudinal surveillance in Shanghai.Frontiers in public health · 2026Article
- Development and validation of a nomogram-based prediction model for hospital-acquired carbapenem-resistant Acinetobacter baumannii in critically ill patients: a multicenter retrospective cohort study.Frontiers in cellular and infection microbiology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Carbapenem-resistant Methods: From 2018 to 2023, long-term environmental monitoring of surfaces around CRAB patients was conducted across 16 hospitals in Shanghai. During each quarter, 48 environmental samples, along with information about the samples, were collected. Bacterial isolates were collected, and antimicrobial susceptibility testing (AST) was performed in accordance with the Clinical and Laboratory Standards Institute (CLSI) guidelines (2019-2021 edition). The CRAB detection rate in the environmental samples was compared across different variables. For nominal categorical variables, intergroup differences were analyzed using Pearson's chi-squared (χ Results: A total of 10,268 samples were included in this study, among which 391 tested positive for CRAB. The overall CRAB positivity rate on environmental surfaces was 3.81%. Significant differences in positivity rates were observed across hospital levels, departments, sampling locations, and exposure frequencies ( Conclusion: Class A secondary hospitals and Class B tertiary hospitals should prioritize infection control measures to prevent the dissemination of CRAB. Special attention should be given to high-risk areas, such as the surgical department and ICU, with enhanced disinfection of high-touch surfaces within patient wards.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.